Matinas BioPharma Holdings Inc (MTNB) is higher by Thursday morning, with the stock rising 7.30% in pre-market trading to 1.47. MTNB's short-term technical score of 41 indicates that the stock has traded less bullishly over the last month than 59% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, the stock ranks higher than 76% of stocks. Matinas BioPharma Holdings Inc has risen 90.28% over the past month, closing at $0.80 on August 26. During this period of time, the stock fell as low as $0.79 and as high as $1.27. MTNB has an average analyst recommendation of Strong Buy. The company has an average price target of $2.48.
MTNB has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on MTNB!